Journal of the American Society of Nephrology (JASN) podcast

ASN Kidney Translation Series: JASN Late-Breaking Clinical Trials

24/10/2026

Journal of the American Society of Nephrology (JASN)

0:00

50:02

This episode of ASN Kidney Translation Podcast, we review 2 late-breaking clinical trials: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. The authors discuss efficacy, safety, and implications for kidney practice

D'autres épisodes de "Journal of the American Society of Nephrology (JASN)"

ASN Kidney Translation Series: JASN Late-Breaking Clinical Trials
il y a 9 heures
50:02
This episode of ASN Kidney Translation Podcast, we review 2 late-breaking clinical trials: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. The authors discuss efficacy, safety, and implications for kidney practice
ASN Kidney Translation Series: 2026 ASN Journals' Trainees of the Year
il y a 3 jours
39:08
ASN Kidney Translation Podcast highlights the 2026 Trainees of the Year: Kidney360 on MRI-based kidney stress testing, CJASN on intratubular cast composition using spatial protein imaging, and JASN on Tenascin C–mediated kidney regeneration in axolotls.
Ne ratez aucun épisode de “Journal of the American Society of Nephrology (JASN)” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.
Dialysis Discontinuation Rates in Patients with AKI
16/10/2026
25:49
Drs. Ian McCoy and Chi-yuan Hsu discuss their study, "Dialysis Discontinuation Rates at Low Levels of Kidney Function in Patients with Acute Kidney Injury on Intermittent Hemodialysis," with JASN Deputy Editor Manjula Kurella Tamura.
SHFM3 Is an IS-Dependent IDO1 E3 Ligase
25/09/2026
22:56
Drs. Chitalia, Almiron, and Sethuraman discuss their study, "Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing IDO1 via the E3 Ligase SHFM3," with JASN Deputy Editor Alan S.L. Yu and Junior Associate Editor Kyle Jansson.
Barriers to Kidney Transplantation in the United States
09/09/2026
21:05
Drs. Conor Donnelly, Michal A. Mankowski, and Allan B. Massie discuss the findings of their study, "Evaluating Barriers to Kidney Transplantation in the United States," with JASN Deputy Editor David H. Ellison and Junior Associate Editor Nathan H. Raines.
ASN Kidney Translation Series: ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome
02/09/2026
29:05
This episode of ASN Kidney Translation Podcast explores the ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic (CKM) Syndrome, discussing key recommendations, risk assessment, and strategies to improve kidney, heart, and metabolic outcomes.
APOL1 at the Plasma Membrane and Cytotoxicity
05/08/2026
26:58
Dr. Oyindamola Christiana Adebayo discusses the results of her study, "Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity," on behalf of her coauthors, with JASN Deputy Editor David H. Ellison.
ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances
29/07/2026
1:06:22
ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).
Temporal, Cell-Specific Angiopoietin-2 in CKD
18/06/2026
19:31
Dr. Fan-Chi Chang discusses findings from her study, "Cell-Specific Roles of Angiopoietin-2 in CKD," with JASN Deputy Editor Alan S.L. Yu.
Cardiovascular Effects of GLP-1 RA in Kidney Failure
12/06/2026
28:03
Drs. Benjamin Catanese and Daniel Edmonston discuss their study, "Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure," with JASN Deputy Editor Manjula Kurella Tamura.

Plus d'épisodes

Découvrez le meilleur des podcasts sur l'application GetPodcast.

Abonnez-vous à tous vos podcasts préférés, écoutez les épisodes sans connexion internet et recevez des recommandations de podcasts passionnants.

© radio.de GmbH 2026

Une entreprise de

MADSACK